Ocular fluorophotometry in the normal- and diabetic monkey

Area of Science:

• Ophthalmology
• Diabetology
• Physiology

Background:

• The blood-ocular barrier (BOB) is crucial for maintaining ocular health.
• Diabetic retinopathy is a leading cause of blindness, but early detection of BOB alterations is challenging.

Purpose of the Study:

• To investigate early changes in the blood-ocular barrier in diabetic non-human primates before the onset of retinopathy.
• To assess the utility of ocular fluorophotometry in detecting subclinical BOB dysfunction.

Main Methods:

• Ocular fluorophotometry was employed in normal and diabetic rhesus monkeys.
• Vitreous and anterior chamber fluorescein levels were measured and normalized.
• Animals included insulin-dependent (pancreatectomized, streptozotocin-treated) and non-insulin-dependent diabetic models, alongside controls.

Main Results:

• Insulin-dependent diabetic monkeys showed significantly higher posterior vitreous fluorescence compared to controls and non-insulin-dependent diabetics.
• These findings were independent of fluorescein binding or vitreous abnormalities.
• No significant differences were observed in anterior chamber fluorescein concentrations between groups.

Conclusions:

• Alterations in the blood-retinal barrier can occur in insulin-dependent diabetes mellitus prior to clinically detectable retinopathy.
• Ocular fluorophotometry is a sensitive method for detecting early BOB dysfunction in diabetes.
• These preclinical changes highlight potential targets for early therapeutic intervention in diabetic eye disease.